The great satisfaction experienced by our scientific teams when they learn that new candidate drugs they are working on are not only effective in sustaining life, but probably even more important improve upon the quality.
Here's how an ex-vp oncology at Genentech remembers it.
http://www.bizjournals.com/sanfranci...&i=health_care